微血管疾病的靶向治疗。

IF 2.5 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart Failure Clinics Pub Date : 2023-11-10 DOI:10.1016/j.hfc.2023.06.003

Adam Bland MBBS , Eunice Chuah MBBS , William Meere MBBS , Thomas J. Ford MBChB (Hons), PhD

引用次数: 0

摘要

冠状动脉微血管功能障碍(CMD)是缺血的常见原因，但不是导致冠状动脉微血管不能满足心肌需氧量的阻塞性冠状动脉疾病。由于缺乏机制研究和靶向治疗，CMD的诊断和管理具有挑战性。最近的证据表明，我们可以根据冠状动脉微循环的侵入性评估所显示的诊断，通过分层的抗心绞痛治疗来改善患者的预后。本文综述了CMD的治疗证据，包括心血管危险的治疗、抗心绞痛治疗和动脉粥样硬化治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Targeted Therapies for Microvascular Disease

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Heart Failure Clinics CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

5.40

自引率

2.90%

发文量

期刊介绍： Heart failure is quickly becoming the most pressing health problem in the United States. Heart Failure Clinics provides practical, concise and easy-to-read coverage that encompasses everything you need to know about the current literature. Topics include acute decompensated heart failure, arrhythmias and sudden cardiac death, ventricular dysfunction, comorbidities of heart failure, diastolic dysfunction, genetic evaluation, ischemic heart disease, pulmonary arterial hypertension, and surgery/transplantation.